Exploring the Potential of Broadly Neutralizing Antibodies for Treating SARS-CoV-2 Variants of Global Concern in 2023: A Comprehensive Clinical Review

In the aftermath of the coronavirus disease 2019 (COVID-19) pandemic, the world is still seeing outbreaks of COVID-19 infections as of 2023, especially in populations that have been adequately vaccinated. This situation across the globe gives rise to important questions regarding the efficacy of cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutlapalli, Sai Dheeraj, Ganipineni, Vijay Durga Pradeep, Danda, Sumanth, Fabian, Daniel, Okorie, Ikpechukwu J, Paramsothy, Jananthan, Kailayanathan, Tharunjan, Umyarova, Rushaniya, Aviles, Cinthya, Garlapati, Sameer Krishna Prasad, Ugwendum, Derek, Nfonoyim, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060008/
https://www.ncbi.nlm.nih.gov/pubmed/37009363
http://dx.doi.org/10.7759/cureus.36809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060008/
https://www.ncbi.nlm.nih.gov/pubmed/37009363
http://dx.doi.org/10.7759/cureus.36809

Ejemplares similares